VIVO Cannabis Inc. (VVCIF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
VIVO Cannabis Inc. (VVCIF) trades at $0.0153 with AI Score 46/100 (Grade C). VIVO Cannabis Inc. produces and sells cannabis products in the medical and adult-use markets across Canada, Germany, and Australia. Market cap: $5.67M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for VVCIF: VVCIF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VVCIF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
VVCIF: 1/3 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
VIVO Cannabis Inc. (VVCIF) Healthcare & Pipeline Overview
VIVO Cannabis Inc. operates in the cannabis industry, focusing on the production and distribution of medical and adult-use cannabis products across Canada, Germany, and Australia. The company distinguishes itself through its vertically integrated model, encompassing cultivation, processing, and distribution via its own brands and medical clinics.
What Is the Investment Thesis for VVCIF?
VIVO Cannabis Inc. presents a speculative investment opportunity within the cannabis sector, driven by its presence in multiple geographic markets and vertically integrated business model. Key value drivers include the expansion of its product lines and the growth of its medical cannabis clinic network. The company's ability to navigate regulatory landscapes in Canada, Germany, and Australia will be crucial for sustained growth. However, investors may want to evaluate the risks associated with operating in a highly competitive and regulated industry, including fluctuating cannabis prices and evolving consumer preferences. The company's market capitalization of $5.67M and beta of 2.12 indicate high volatility and sensitivity to market movements.
Based on FMP financials and quantitative analysis
VVCIF Key Highlights
Operates in the medical and adult-use cannabis markets in Canada, Germany, and Australia.
- Offers a range of cannabis products, including dried flower, pre-rolls, and cannabis oils under various brands.
- Operates a network of medical cannabis clinics under the Harvest Medicine brand.
- Utilizes the HMED Connect telemedicine platform for online medical cannabis services.
- Engages in ethanol extraction, product formulation, and EU-GMP related processes.
Who Are VVCIF's Competitors?
VVCIF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BCBCF The BC Bud Corporation | $0.04 | -3.31% | $5.98M | 56 |
| CLSH CLS Holdings USA, Inc. | $0.04 | +0.00% | $5.94M | 43 |
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VVCIF's Key Strengths?
Vertically integrated operations.
- Established brands in the cannabis market.
- Network of medical cannabis clinics.
- Presence in multiple international markets.
What Are VVCIF's Weaknesses?
Limited financial resources compared to larger competitors.
- Dependence on regulatory approvals and changes.
- Exposure to fluctuating cannabis prices.
- Relatively small market capitalization.
What Could Drive VVCIF Stock Higher?
Expansion of operations in Germany and Australia.
- Development and launch of new cannabis products.
- Potential strategic partnerships and acquisitions.
- Growth of the medical cannabis market.
- Increasing acceptance of cannabis for medical and recreational use.
What Are the Key Risks for VVCIF?
Negative return on equity (-78.1%) — the business is not currently generating profit on shareholder capital.
- Changes in regulations and laws governing cannabis.
- Intense competition from other cannabis companies.
- Fluctuations in cannabis prices.
- Negative public perception of cannabis.
- Limited access to capital and financing.
What Are the Growth Opportunities for VVCIF?
- Expansion of International Operations: VIVO Cannabis has the opportunity to expand its operations in Germany and Australia, leveraging the increasing acceptance of medical cannabis in these regions. The European cannabis market is projected to experience substantial growth, presenting a significant opportunity for VIVO Cannabis to increase its market share. Timeline: Ongoing, with potential for accelerated growth in the next 2-3 years.
- Product Innovation and Diversification: VIVO Cannabis can drive growth by introducing new and innovative cannabis products, catering to evolving consumer preferences. This includes developing new formulations, delivery methods, and product formats. Market research and development efforts can help identify emerging trends and unmet needs in the cannabis market. Timeline: Ongoing, with new product launches expected in the next 12-18 months.
- Strategic Partnerships and Acquisitions: VIVO Cannabis can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. Collaborating with other cannabis companies or acquiring complementary businesses can provide access to new markets, technologies, and expertise. Timeline: Opportunistic, with potential for strategic deals in the next 1-2 years.
- Development of Value-Added Cannabis Products: VIVO Cannabis can focus on developing value-added cannabis products, such as edibles, concentrates, and topicals, to increase its revenue and profitability. These products typically command higher prices and margins compared to traditional cannabis flower products. Timeline: Ongoing, with a focus on expanding the value-added product portfolio in the next 12 months.
- Expansion of Medical Cannabis Clinic Network: VIVO Cannabis can expand its network of medical cannabis clinics to increase access to medical cannabis for patients in need. This includes opening new clinics in underserved areas and expanding the services offered at existing clinics. The medical cannabis market is expected to continue to grow as more patients seek cannabis-based treatments for various medical conditions. Timeline: Ongoing, with plans to open new clinics in the next 2 years.
What Are VVCIF's Competitive Advantages?
- Vertically integrated operations, encompassing cultivation, processing, and distribution.
- Established brands with recognition in the cannabis market.
- Network of medical cannabis clinics providing direct access to patients.
- Presence in multiple international markets, diversifying revenue streams.
What Does VVCIF Do?
VIVO Cannabis Inc., headquartered in Napanee, Canada, is a cannabis company focused on producing and selling cannabis products for both medical and adult-use markets. Founded with the vision of providing high-quality cannabis products, VIVO Cannabis operates across Canada, Germany, and Australia. The company's product portfolio includes dried cannabis flower products, pre-rolls, and cannabis oils, marketed under brands such as Canna Farms, Beacon Medical, Fireside, and Lumina. VIVO Cannabis also operates a network of medical cannabis clinics under the Harvest Medicine brand, complemented by the HMED Connect telemedicine platform, offering online medical cannabis consultations and services. The company's operations include ethanol extraction, product formulation, and adherence to EU-GMP standards, ensuring product quality and consistency. VIVO Cannabis aims to establish a strong market presence through its diversified product offerings and distribution channels, catering to both medical and recreational cannabis consumers.
What Products and Services Does VVCIF Offer?
- Produces and sells dried cannabis flower products.
- Manufactures and distributes pre-rolls.
- Offers cannabis oils for medical and recreational use.
- Operates under the Canna Farms, Beacon Medical, Fireside, and Lumina brands.
- Manages a network of medical cannabis clinics under the Harvest Medicine brand.
- Provides online medical cannabis services through the HMED Connect telemedicine platform.
- Engages in ethanol extraction and product formulation.
- Adheres to EU-GMP standards in its production processes.
How Does VVCIF Make Money?
- Cultivation and processing of cannabis.
- Sale of cannabis products through retail channels and medical clinics.
- Provision of medical cannabis consultations and services.
- Distribution of products in Canada, Germany, and Australia.
What Industry Does VVCIF Operate In?
VIVO Cannabis Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth driven by increasing legalization and acceptance of cannabis for medical and recreational purposes. The market is characterized by intense competition, with numerous players vying for market share. VIVO Cannabis differentiates itself through its presence in multiple international markets and its vertically integrated business model.
Who Are VVCIF's Key Customers?
- Medical cannabis patients seeking cannabis-based treatments.
- Adult-use cannabis consumers in legal markets.
- Retail partners and distributors.
- Healthcare professionals prescribing medical cannabis.
Company Profile
VIVO Cannabis Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Napanee, CA. The company is led by CEO Joseph Louis Raymond Laflamme. VVCIF has traded publicly since 2018.
VIVO Cannabis Inc. (VVCIF) Valuation Context
Valued at $5.67M, VVCIF is classified as a micro-cap stock. Relative to its peer group, VVCIF's quantitative score of 46/100 is below the peer average of 57/100.
Key Financial Metrics
Return on equity for VIVO Cannabis Inc. stands at -78.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -72.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.15 indicates the company holds enough short-term assets to cover its near-term obligations.
VVCIF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Established brands in the cannabis market.
- Network of medical cannabis clinics.
- Presence in multiple international markets.
Bear Case
- Limited financial resources compared to larger competitors.
- Dependence on regulatory approvals and changes.
- Exposure to fluctuating cannabis prices.
- Relatively small market capitalization.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
VVCIF Latest News
No recent news available for VVCIF.
VVCIF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VVCIF.
Price Targets
Wall Street price target analysis for VVCIF.
VVCIF MoonshotScore
What does this score mean?
The MoonshotScore rates VVCIF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Joseph Louis Raymond Laflamme
CEO
Joseph Louis Raymond Laflamme serves as the CEO of VIVO Cannabis Inc. His background includes experience in managing teams and overseeing operations within the cannabis industry. Laflamme's leadership is focused on driving the company's growth strategy, expanding its market presence, and ensuring operational efficiency. His expertise is crucial for navigating the complex regulatory landscape and fostering innovation within the company.
Track Record: Under Laflamme's leadership, VIVO Cannabis has focused on expanding its international operations and developing new cannabis products. Key milestones include strengthening the company's presence in Germany and Australia, as well as enhancing its product portfolio to meet evolving consumer demands. Laflamme has also emphasized the importance of maintaining high standards of quality and compliance in all aspects of the company's operations.
VVCIF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) securities. Companies in this tier often have limited financial disclosure and may not meet the minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other securities carries significant risks due to the lack of regulatory oversight and potential for fraud. Investors should exercise extreme caution and conduct thorough due diligence before investing in these securities.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for fraud and manipulation.
- Low trading volume and liquidity.
- Higher price volatility compared to exchange-listed stocks.
- Lack of regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs.
- Understand the risks associated with investing in OTC securities.
- Consult with a financial advisor before making any investment decisions.
- Operating history in the cannabis industry.
- Presence in multiple geographic markets.
- Network of medical cannabis clinics.
- Partnerships with reputable organizations.
- Adherence to EU-GMP standards.
VVCIF Healthcare Stock FAQ
What does the AI Score mean for VVCIF?
VVCIF holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. VIVO Cannabis Inc. produces and sells cannabis products in the medical and adult-use markets across Canada, Germany, and Australia. The company offers a range of cannabis products and operates …
What does VIVO Cannabis Inc. do?
VIVO Cannabis Inc. is a cannabis company that produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. The company offers a range of cannabis products, including dried flower, pre-rolls, and cannabis oils, under various brands.
What are the main risks for VVCIF?
VIVO Cannabis Inc. faces several risks, including regulatory uncertainty, intense competition, and fluctuating cannabis prices. Changes in regulations and laws governing cannabis could negatively impact the company's operations and financial performance. The cannabis market is highly competitive, with numerous players vying for market share. Fluctuations in cannabis prices can affect the company's revenue and profitability. Additionally, negative public perception of cannabis could limit the company's growth potential.
What revenue streams does VIVO Cannabis Inc. have in healthcare?
VIVO Cannabis Inc.'s revenue streams in healthcare are derived from the sale of medical cannabis products, the operation of medical cannabis clinics under the Harvest Medicine brand, and the provision of online medical cannabis services through the HMED Connect telemedicine platform. Revenue is generated from the sale of dried cannabis flower, pre-rolls, and cannabis oils to medical patients.
How does VIVO Cannabis Inc. navigate regulatory approval processes?
VIVO Cannabis Inc. navigates regulatory approval processes by adhering to strict quality control standards and complying with all applicable laws and regulations in the jurisdictions where it operates. The company maintains EU-GMP certification for its production facilities, ensuring that its products meet the highest standards of quality and safety.
What are the key factors to evaluate for VVCIF?
VIVO Cannabis Inc. (VVCIF) holds an AI score of 46/100 (low). presents a speculative investment opportunity within the cannabis sector, driven by its presence in multiple geographic markets and vertically integrated business model. Not financial advice.
How frequently does VVCIF data refresh on this page?
VVCIF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven VVCIF's recent stock price performance?
VIVO Cannabis Inc. (VVCIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VVCIF overvalued or undervalued right now?
VIVO Cannabis Inc. (VVCIF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be limited or delayed.
- AI analysis pending for VVCIF.